$23.160
+0.081 (+0.35%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
VRDN Prediction & Forecast by Similar Chart Analysis
Alphio's VRDN stock price prediction model matches the current Viridian Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $23.17 (+0.60%). The 1-week path is $22.64 (-1.69%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Viridian Therapeutics Inc Stock?
Viridian Therapeutics (VRDN) appears to be a good buy right now, trading at $23.08 with a forward P/E of 1.0072, indicating potential undervaluation. The recent FDA approval for Lumvoa therapy for thyroid eye disease is a significant positive catalyst, expected to drive revenue growth. However, the current RSI of 38.888 suggests the stock is near oversold territory, which could lead to a rebound. The main risk is the negative net income of -127,119,000 USD reported in Q2 2026, which reflects ongoing financial challenges that investors should monitor closely.
VRDN stock price ended at $23.16 on Monday, after rising +0.35%
Viridian Therapeutics Inc (VRDN) last closed at $23.03, losing -0.56%. These facts feed the 1-day and 1-week VRDN price prediction above.
Forecast Drivers
Viridian Therapeutics Inc (VRDN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches VRDN, ranked by similarity.
Seasonality analysis for VRDN
Historically the probability of a positive September return for VRDN is 23.81%. October offers the highest probability of a positive month at 93.48%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for VRDN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $8.18 | $11.41 | $13.25 | -50.44% |
| Oct 2026 | $11.92 | $13.50 | $13.82 | -41.38% |
| Nov 2026 | $12.29 | $12.44 | $16.30 | -45.97% |
| Dec 2026 | $11.34 | $13.54 | $17.31 | -41.20% |
In 2026, Viridian Therapeutics Inc (VRDN) is projected to range from $8.18 to $17.31.
Viridian Therapeutics Inc 2026 monthly forecast
In Sep 2026, Viridian Therapeutics Inc is projected to average $11.41, with a low of $8.18 and high of $13.25.
In Oct 2026, Viridian Therapeutics Inc is projected to average $13.50, with a low of $11.92 and high of $13.82.
In Nov 2026, Viridian Therapeutics Inc is projected to average $12.44, with a low of $12.29 and high of $16.30.
In Dec 2026, Viridian Therapeutics Inc is projected to average $13.54, with a low of $11.34 and high of $17.31.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.